Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Carnahan

Showing results (111-120 of 141) with videos related to

Pageof 15
Sort By:
The Journal of Clinical Investigation|April 26, 2022
An antibody targeting the N-terminal domain of SARS-CoV-2 disrupts the spike trimerNaveenchandra Suryadevara, Andrea R Shiakolas, Laura A VanBlargan, et al.
Cell Reports|August 19, 2021
Convergent antibody responses to the SARS-CoV-2 spike protein in convalescent and vaccinated individualsElaine C Chen, Pavlo Gilchuk, Seth J Zost, et al.
Biorxiv : the Preprint Server for Biology|September 16, 2020
Complete mapping of mutations to the SARS-CoV-2 spike receptor-binding domain that escape antibody recognitionAllison J Greaney, Tyler N Starr, Pavlo Gilchuk, et al.
Cell Host & Microbe|December 1, 2020
Complete Mapping of Mutations to the SARS-CoV-2 Spike Receptor-Binding Domain that Escape Antibody RecognitionAllison J Greaney, Tyler N Starr, Pavlo Gilchuk, et al.
Cell Metabolism|November 20, 2018
Ectonucleoside Triphosphate Diphosphohydrolase-3 Antibody Targets Adult Human Pancreatic β Cells for In Vitro and In Vivo AnalysisDiane C Saunders, Marcela Brissova, Neil Phillips, et al.
Cell Reports|April 8, 2023
Systematic analysis of human antibody response to ebolavirus glycoprotein shows high prevalence of neutralizing public clonotypesElaine C Chen, Pavlo Gilchuk, Seth J Zost, et al.
Iscience|December 13, 2021
Standardized two-step testing of antibody activity in COVID-19 convalescent plasmaPavlo Gilchuk, Isaac Thomsen, Sandra Yoder, et al.
Cell Reports|September 30, 2021
Potent neutralization of SARS-CoV-2 variants of concern by an antibody with an uncommon genetic signature and structural mode of spike recognitionKevin J Kramer, Nicole V Johnson, Andrea R Shiakolas, et al.
Med (New York, N.Y.)|February 8, 2022
A combination of two human neutralizing antibodies prevents SARS-CoV-2 infection in cynomolgus macaquesRonald R Cobb, Joseph Nkolola, Pavlo Gilchuk, et al.
Cell Host & Microbe|May 15, 2020
Identification of Dengue Virus Serotype 3 Specific Antigenic Sites Targeted by Neutralizing Human AntibodiesEllen Young, Robert H Carnahan, Daniela V Andrade, et al.
Pageof 15

Showing results (111-120 of 141) with videos related to

Sort By:
Pageof 15
The Journal of Clinical Investigation|April 26, 2022
An antibody targeting the N-terminal domain of SARS-CoV-2 disrupts the spike trimerNaveenchandra Suryadevara, Andrea R Shiakolas, Laura A VanBlargan, et al.
Cell Reports|August 19, 2021
Convergent antibody responses to the SARS-CoV-2 spike protein in convalescent and vaccinated individualsElaine C Chen, Pavlo Gilchuk, Seth J Zost, et al.
Biorxiv : the Preprint Server for Biology|September 16, 2020
Complete mapping of mutations to the SARS-CoV-2 spike receptor-binding domain that escape antibody recognitionAllison J Greaney, Tyler N Starr, Pavlo Gilchuk, et al.
Cell Host & Microbe|December 1, 2020
Complete Mapping of Mutations to the SARS-CoV-2 Spike Receptor-Binding Domain that Escape Antibody RecognitionAllison J Greaney, Tyler N Starr, Pavlo Gilchuk, et al.
Cell Metabolism|November 20, 2018
Ectonucleoside Triphosphate Diphosphohydrolase-3 Antibody Targets Adult Human Pancreatic β Cells for In Vitro and In Vivo AnalysisDiane C Saunders, Marcela Brissova, Neil Phillips, et al.
Cell Reports|April 8, 2023
Systematic analysis of human antibody response to ebolavirus glycoprotein shows high prevalence of neutralizing public clonotypesElaine C Chen, Pavlo Gilchuk, Seth J Zost, et al.
Iscience|December 13, 2021
Standardized two-step testing of antibody activity in COVID-19 convalescent plasmaPavlo Gilchuk, Isaac Thomsen, Sandra Yoder, et al.
Cell Reports|September 30, 2021
Potent neutralization of SARS-CoV-2 variants of concern by an antibody with an uncommon genetic signature and structural mode of spike recognitionKevin J Kramer, Nicole V Johnson, Andrea R Shiakolas, et al.
Med (New York, N.Y.)|February 8, 2022
A combination of two human neutralizing antibodies prevents SARS-CoV-2 infection in cynomolgus macaquesRonald R Cobb, Joseph Nkolola, Pavlo Gilchuk, et al.
Cell Host & Microbe|May 15, 2020
Identification of Dengue Virus Serotype 3 Specific Antigenic Sites Targeted by Neutralizing Human AntibodiesEllen Young, Robert H Carnahan, Daniela V Andrade, et al.
Pageof 15